We are live on ! Find out more
EGRX

Eagle Pharmaceuticals, Inc.
EGRX

Delisted

EGRX was delisted on the 2nd of October, 2024.

Back to rankings

147 hedge funds and large institutions have $1.36B invested in Eagle Pharmaceuticals, Inc. in 2017 Q1 according to their latest regulatory filings, with 26 funds opening new positions, 51 increasing their positions, 49 reducing their positions, and 22 closing their positions.

New
Increased
Maintained
Reduced
Closed

216% more call options, than puts

Call options by funds: $12.2M | Put options by funds: $3.85M

18% more first-time investments, than exits

New positions opened: 26 | Existing positions closed: 22

4% more capital invested

Capital invested by funds: $1.31B → $1.36B (+$57.9M)

4% more repeat investments, than reductions

Existing positions increased: 51 | Existing positions reduced: 49

1% less funds holding

Funds holding: 149 → 147 (-2)

50% less funds holding in top 10

Funds holding in top 10: 6 → 3 (-3)

Holders
147
Holders Change
-2
Holders Change %
-1.34%
% of All Funds
3.66%
Holding in Top 10
3
Holding in Top 10 Change
-3
Holding in Top 10 Change %
-50%
% of All Funds
0.07%
New
26
Increased
51
Reduced
49
Closed
22
Calls
$12.2M
Puts
$3.85M
Net Calls
+$8.31M
Net Calls Change
+$6.08M

Top Buyers

Rank Fund Capital Flow
1
BlackRock
BlackRock
New York
+$89.7M
2
IAM
Iridian Asset Management
Connecticut
+$53.2M
3
Fidelity Investments
Fidelity Investments
Massachusetts
+$17M
4
Victory Capital Management
Victory Capital Management
Texas
+$15.6M
5
RHJA
Rice Hall James & Associates
California
+$9.72M

Top Sellers

Rank Fund Capital Flow
1
PA
Perceptive Advisors
New York
-$39.5M
2
PAI
ProQuest Associates IV
Florida
-$22.3M
3
CAM
Cormorant Asset Management
Massachusetts
-$15.6M
4
CM
Castleark Management
Illinois
-$9.24M
5
Citadel Advisors
Citadel Advisors
Florida
-$7.89M
Name Holding Trade Value Shares
Change 		Change in
Stake
ASN
76
Advisory Services Network
Georgia
$664K +$595K +8,000 New
SO
77
STRS Ohio
Ohio
$663K +$595K +8,000 New
D.E. Shaw & Co
78
D.E. Shaw & Co
New York
$650K +$583K +7,843 New
Fisher Asset Management
79
Fisher Asset Management
Washington
$637K +$141K +1,900 +33%
State of Tennessee, Department of Treasury
80
State of Tennessee, Department of Treasury
Tennessee
$621K +$84K +1,130 +18%
Dimensional Fund Advisors
81
Dimensional Fund Advisors
Texas
$617K – – –
Manulife (Manufacturers Life Insurance)
82
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$587K +$63K +848 +14%
AWCI
83
Alpine Woods Capital Investors
New York
$581K – – –
CIP
84
Convergence Investment Partners
Florida
$579K +$519K +6,982 New
FFEC
85
First Financial Equity Corporation
Arizona
$570K +$511K +6,872 New
MLICM
86
Metropolitan Life Insurance Company (MetLife)
New York
$517K – – –
MF
87
Magnetar Financial
Illinois
$517K +$463K +6,229 New
SAM
88
Symphony Asset Management
California
$513K +$460K +6,190 New
T. Rowe Price Associates
89
T. Rowe Price Associates
Maryland
$512K -$372K -5,000 -45%
CCMH
90
Cornerstone Capital Management Holdings
New York
$511K +$459K +6,176 New
AA
91
ALPS Advisors
Colorado
$495K +$444K +5,969 New
TPSF
92
Texas Permanent School Fund
Texas
$487K +$9.29K +125 +2%
WPC
93
White Pine Capital
Minnesota
$473K +$2.23K +30 +0.5%
Public Sector Pension Investment Board (PSP Investments)
94
Public Sector Pension Investment Board (PSP Investments)
Quebec, Canada
$464K – – –
Royal Bank of Canada
95
Royal Bank of Canada
Ontario, Canada
$464K +$115K +1,543 +38%
AIG
96
American International Group
New York
$452K -$65.5K -881 -14%
State Board of Administration of Florida Retirement System
97
State Board of Administration of Florida Retirement System
Florida
$440K – – –
Wellington Management Group
98
Wellington Management Group
Massachusetts
$406K +$364K +4,897 New
Thrivent Financial for Lutherans
99
Thrivent Financial for Lutherans
Minnesota
$382K +$29.7K +400 +10%
RSS
100
Rosenblum Silverman Sutton
California
$354K -$1.86K -25 -0.6%
2 3
4
5 6

EGRX Hedge Fund Activity: Q1 2017 in Review

147 of the 4,018 institutional investors tracked by Wall St. Rank reported a position in Eagle Pharmaceuticals, Inc. (EGRX) for Q1 2017, worth a combined $1.36B — up 4.4% from $1.31B a quarter earlier.

Buyers outnumbered sellers: 26 funds opened new EGRX positions and 22 closed out — a net gain of 4 holders — while 51 added to existing stakes and 49 trimmed.

The largest buyer was BlackRock, adding an estimated $89.7M. The largest seller was Perceptive Advisors, exiting entirely with an estimated $39.5M sold.

  • 147 institutional investors held Eagle Pharmaceuticals, Inc. (EGRX) as of Q1 2017, down from 149 in Q4 2016.
  • Funds reported $1.36B of Eagle Pharmaceuticals, Inc. stock for Q1 2017, up 4.4% quarter-over-quarter.
  • 26 funds opened new Eagle Pharmaceuticals, Inc. positions in Q1 2017 and 22 closed out, a net change of +4 holders.
  • The largest Eagle Pharmaceuticals, Inc. buyer in Q1 2017 was BlackRock, an estimated $89.7M added.
  • The largest Eagle Pharmaceuticals, Inc. seller in Q1 2017 was Perceptive Advisors, an estimated $39.5M sold.

Based on aggregated 13F filings for Q1 2017.